辉瑞制药Pfizer-201501-AdvancingDifferentiatedHighVaueProducts-JPMorganHeathcareConference_By_MD

JPMorganHealthcareConferenceAdvancingDifferentiatedHighValueProductsMikaelDolsten,M.D.,Ph.D.PresidentWorldwideR&DJanuary13,2015Forward-lookingStatements2?Thispresentationincludesforward-lookingstatementsabout,amongotherthings,developmentofPfizer’sproductsandproductcandidates,includingtheirpotentialbenefits,expectedclinicaltrialstudystartsandexpectedregulatorysubmissionsandapprovalsthataresubjecttosubstantialrisksanduncertaintiesthatcouldcauseactualresultstodiffermateriallyfromthoseexpressedorimpliedbysuchstatements.AdditionalinformationregardingthesefactorscanbefoundinPfizer’sAnnualReportonForm10-KforthefiscalyearendedDecember31,2013andinoursubsequentreportsonForm10-Q,includinginthesectionsthereofcaptioned“RiskFactors”and“Forward-LookingInformationThatMayAffectFutureResults”,aswellasinoursubsequentreportsonForm8-K,allof